Terns Pharmaceuticals, Inc. (TERN) Tops Q4 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts TERN Hot Sheet
Join SI Premium – FREE
Terns Pharmaceuticals, Inc. (NASDAQ: TERN) reported Q4 EPS of ($0.24), $0.06 better than the analyst estimate of ($0.30).
For earnings history and earnings-related data on Terns Pharmaceuticals, Inc. (TERN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Moderna shares plunge on cancer vaccine data leak
- Northrim BanCorp and PBCO win shareholder votes for merger
- Zurn Water Solutions Corporation (ZWS) Declares $0.13 Quarterly Dividend; 1.1% Yield
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
